Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Plos One|December 13, 2016
Mutant PIK3CA Induces EMT in a Cell Type Specific MannerDivya Bhagirath, Xiangshan Zhao, Sameer Mirza, et al.
European Journal of Pharmacology|February 8, 2026
Therapeutic Potential and Pharmacological Mechanisms of Cannabinoids in Alleviating Chemotherapy-Induced Organ Toxicity and Adverse EffectsBushra Zia, M F Nagoor Meeran, Charu Sharma, et al.
Life Sciences|March 27, 2007
Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patientsGayatri Sharma, Sameer Mirza, Chandra P Prasad, et al.
Current Research in Pharmacology and Drug Discovery|February 3, 2026
Therapeutic potential, pharmacological role and molecular mechanisms of adelmidrol, an analogue of palmitoylethanolamideBushra Zia, Abdulrahman Alkaabi, Niraj Kumar Jha, et al.
Pathology, Research and Practice|February 13, 2026
Epithelial-mesenchymal transition (EMT) and cellular plasticity in Ovarian cancerAfsheen Raza, Sadaf Khursheed Baba, Dina Moustafa Abo El-Ella, et al.
Clinical Biochemistry|November 3, 2009
CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patientsGayatri Sharma, Sameer Mirza, Rajinder Parshad, et al.
The Journal of Biological Chemistry|October 3, 2015
Alteration/Deficiency in Activation 3 (ADA3) Protein, a Cell Cycle Regulator, Associates with the Centromere through CENP-B and Regulates Chromosome SegregationShakur Mohibi, Shashank Srivastava, Jun Wang-France, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 11, 2010
Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expressionGayatri Sharma, Sameer Mirza, Rajinder Parshad, et al.
Pageof 7